Center for Chromosome Stability, Institute for Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
DNA Metabolism Laboratory, FIRC Institute for Molecular Oncology (IFOM), Milan 20139, Italy.
Cell Rep. 2020 Feb 18;30(7):2416-2429.e7. doi: 10.1016/j.celrep.2020.01.067.
It has been long assumed that normally leading strand synthesis must proceed coordinated with the lagging strand to prevent strand uncoupling and the pathological accumulation of single-stranded DNA (ssDNA) in the cell, a dogma recently challenged by in vitro studies in prokaryotes. Here, we report that human DNA polymerases can function independently at each strand in vivo and that the resulting strand uncoupling is supported physiologically by a cellular tolerance to ssDNA. Active forks rapidly accumulate ssDNA at the lagging strand when POLA1 is inhibited without triggering a stress response, despite ssDNA formation being considered a hallmark of replication stress. Acute POLA1 inhibition causes a lethal RPA exhaustion, but cells can duplicate their DNA with limited POLA1 activity and exacerbated strand uncoupling as long as RPA molecules suffice to protect the elevated ssDNA. Although robust, this uncoupled mode of DNA replication is also an in-built weakness that can be targeted for cancer treatment.
长期以来,人们一直认为正常的前导链合成必须与滞后链协调进行,以防止链解偶联和细胞中单链 DNA(ssDNA)的病理性积累,这一教条最近受到了原核生物体外研究的挑战。在这里,我们报告说,人类 DNA 聚合酶可以在体内独立于每条链发挥作用,并且由此产生的链解偶联在生理上得到了细胞对 ssDNA 的耐受性的支持。当 POLA1 被抑制时,活性叉会在前导链上迅速积累 ssDNA,而不会引发应激反应,尽管 ssDNA 的形成被认为是复制应激的标志。急性 POLA1 抑制会导致致命的 RPA 耗尽,但只要 RPA 分子足以保护升高的 ssDNA,细胞就可以在有限的 POLA1 活性和加剧的链解偶联下复制其 DNA。虽然这种 DNA 复制的解偶联模式很强大,但它也是一种内在的弱点,可以作为癌症治疗的靶点。